PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Nearly all benchtop studies of corneal biomechanics have relied on protocols which stiffen the cornea, such as riboflavin-UV crosslinking, as a way of providing contrast and validation of biomechanical measurements. However, there are strong clinical motivations to detect softening of the cornea. In this work, we present the evidence that phase-decorrelation OCT (PhD-OCT) is able to detect a small degree of corneal softening due to enzymatic digestion. This benchtop study supports the idea that PhD-OCT may detect keratoconus and early ectasia clinically.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Brecken J. Blackburn, John P. Murray, Matthew R. Ford, Michael W. Jenkins, William J. Dupps Jr., Andrew M. Rollins, "Phase-decorrelation OCT for detection of corneal softening in an enzymatic ex vivo model of ectasia (Conference Presentation)," Proc. SPIE 11218, Ophthalmic Technologies XXX, 112180W (9 March 2020); https://doi.org/10.1117/12.2546557